Xcyte Therapies, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Xcyte Therapies, Inc. - overview
Location
Seattle, WA-Washington, US
Primary Industry
Biotechnology
About
Xcyte Therapies, Inc. is a US-based company that operates as a developer of therapeutic products that enhance the body’s natural immune responses to treat cancer, infectious diseases, and other medical conditions associated with weakened immune systems.
Current Investors
Alta Partners, ARCH Venture Partners, Sprout Group
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Epidemiology
Verticals
HealthTech
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Xcyte Therapies, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.